BCIQ Profiles

Company Profile Report
0409 AACR Bispecifics
BioCentury & Getty Images

Product Development

Bispecific constructs move beyond T cell engagers at AACR

Next-generation immune cell engagers and bispecific checkpoints gain ground on T cell engagers at AACR21

Next-generation immune cell engagers and bispecific checkpoints gain ground on T cell engagers at AACR21.

Apr 10, 2021 | 3:01 AM GMT

T cell engagers have dominated the bispecific antibody scene for the past five years, but the industry is starting to branch out into next-generation structures that offer new functions and potential improvements over first-generation compounds. 

BioCentury’s analysis of the

Read the full 885 word article

How to gain access

Continue reading with a
two-week free trial.